New peer-reviewed publication validates nexalin's deep intracranial frequency stimulation (difs) technology, reinforcing leadership in high-growth neuromodulation market

Report highlights nexalin's unique non-invasive solution addressing deep brain dysfunction, positioned to revolutionize mental health treatment report highlights nexalin's unique non-invasive solution addressing deep brain dysfunction, positioned to revolutionize mental health treatment
NXL Ratings Summary
NXL Quant Ranking